SEARCH

SEARCH BY CITATION

References

  • Amadori, S., Arcese, W., Isacchi, G., Meloni, G., Petti, M.C., Monarca, B., Testi, A.M. & Mandelli, F. (1991) Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia. Journal of Clinical Oncology, 9, 12101214.
  • Camera, A., Annino, L., Chiurazzi, F., Fazi, P., Cascavilla, N., Fabbiano, F., Marmont, F., Di Raimondo, F., Recchia, A., Vignetti, M., Rotoli, B. & Mandelli, F. (2004) GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. Haematologica, 89, 145153.
  • Cornelissen, J.J., van der Holt, B., Verhoef, G.E., van't Veer, M.B., van Oers, M.H., Schouten, H.C., Ossenkoppele, G., Sonneveld, P., Maertens, J., van Marwijk Kooy, M., Schaafsma, M.R., Wijermans, P.W., Biesma, D.H., Wittebol, S., Voogt, P.J., Baars, J.W., Zachee, P., Verdonck, L.F., Lowenberg, B. & Dekker, A.W. (2009) Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood, 113, 13751382.
  • Fielding, A.K., Richards, S.M., Chopra, R., Lazarus, H.M., Litzow, M.R., Buck, G., Durrant, I.J., Luger, S.M., Marks, D.I., Franklin, I.M., McMillan, A.K., Tallman, M.S., Rowe, J.M. & Goldstone, A.H. (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood, 109, 944950.
  • Garcia-Manero, G. & Thomas, D.A. (2001) Salvage therapy for refractory or relapsed acute lymphocytic leukemia. Hematology/oncology Clinics of North America, 15, 163205.
  • Giona, F., Annino, L., Rondelli, R., Arcese, W., Meloni, G., Testi, A.M., Moleti, M.L., Amadori, S., Resegotti, L., Tabilio, A., Ladogana, S., Fioritoni, G., Camera, A., Liso, V., Leoni, P. & Mandelli, F. (1997) Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol. British Journal of Haematology, 97, 896903.
  • Gokbuget, N., Stanze, D., Beck, J., Diedrich, H., Horst, H.A., Huttmann, A., Kobbe, G., Kreuzer, K.A., Leimer, , L., Reichle, A., Schaich, M., Schwartz, S., Serve, H., Starck, M., Stelljes, M., Viardot, A., Wendelin, K., Freund, M., Hoelzer, D. (2012) Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood, 120, 20322041.
  • Jinnai, I., Sakura, T., Tsuzuki, M., Maeda, Y., Usui, N., Kato, M., Okumura, H., Kyo, T., Ueda, Y., Kishimoto, Y., Yagasaki, F., Tsuboi, K., Horiike, S., Takeuchi, J., Iwanaga, M., Miyazaki, Y., Miyawaki, S., Ohnishi, K., Naoe, T. & Ohno, R. (2010) Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. International Journal of Hematology, 92, 490502.
  • Kanda, Y. (2012) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplantation, Epub ahead of Print, December 3, 2012; doi:10.1038/bmt.2012.244
  • Kantarjian, H.M., Estey, E.H., Plunkett, W., Keating, M.J., Walters, R.S., Iacoboni, S., McCredie, K.B. & Freireich, E.J. (1986) Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. American Journal of Medicine, 81, 387394.
  • Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C.S., Keating, M.J., Murphy, S. & Freireich, E.J. (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology, 18, 547561.
  • Koller, C.A., Kantarjian, H.M., Thomas, D., O'Brien, S., Rios, M.B., Kornblau, S., Murphy, S. & Keating, M. (1997) The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia, 11, 20392044.
  • Lejeune, C., Tubiana, N., Gastaut, J.A., Maraninchi, D., Richard, B., Launay, M.C., Sainty, D., Sebahoun, G. & Carcassonne, Y. (1990) High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients. European Journal of Haematology, 44, 240243.
  • Litzow, M.R. (2009) Evolving paradigms in the therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults. Hematology/ the Education Program of the American Society of Hematology, 362370.
  • Montillo, M., Tedeschi, A., Centurioni, R. & Leoni, P. (1997) Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leukaemia & Lymphoma, 25, 579583.
  • Oriol, A., Vives, S., Hernandez-Rivas, J.M., Tormo, M., Heras, I., Rivas, C., Bethencourt, C., Moscardo, F., Bueno, J., Grande, C., del Potro, E., Guardia, R., Brunet, S., Bergua, J., Bernal, T., Moreno, M.J., Calvo, C., Bastida, P., Feliu, E. & Ribera, J.M. (2010) Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica, 95, 589596.
  • Ottmann, O.G. & Pfeifer, H. (2009) Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Hematology/ the Education Program of the American Society of Hematology, 371381.
  • Sakura, T., Hayakawa, F., Yujiri, T., Aoyama, Y., Kondo, E., Fujimaki, K., Ueda, Y., Ohtake, S., Miyazaki, Y., Miyawaki, S., Ohnishi, K. & Naoe, T. (2012) Outcome of Pediatric-Type Therapy for Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA): a Study by the Japan Adult Leukemia Study Group (JALSG ALL202-U study). Blood, 120, 1464.
  • Specchia, G., Pastore, D., Carluccio, P., Liso, A., Mestice, A., Rizzi, R., Ciuffreda, L., Pietrantuono, G. & Liso, V. (2005) FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. Annals of Hematology, 84, 792795.
  • Takeuchi, J., Kyo, T., Naito, K., Sao, H., Takahashi, M., Miyawaki, S., Kuriyama, K., Ohtake, S., Yagasaki, F., Murakami, H., Asou, N., Ino, T., Okamoto, T., Usui, N., Nishimura, M., Shinagawa, K., Fukushima, T., Taguchi, H., Morii, T., Mizuta, S., Akiyama, H., Nakamura, Y., Ohshima, T. & Ohno, R. (2002) Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia, 16, 12591266.
  • Tavernier, E., Boiron, J.M., Huguet, F., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lheritier, V., Vernant, J.P., Dombret, H. & Thomas, X. (2007) Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia, 21, 19071914.
  • Thomas, D.A., Kantarjian, H., Smith, T.L., Koller, C., Cortes, J., O'Brien, S., Giles, F.J., Gajewski, J., Pierce, S. & Keating, M.J. (1999) Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer, 86, 12161230.
  • Weiss, M.A., Aliff, T.B., Tallman, M.S., Frankel, S.R., Kalaycio, M.E., Maslak, P.G., Jurcic, J.G., Scheinberg, D.A. & Roma, T.E. (2002) A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer, 95, 581587.